focus -WSS

focus

author：explore 2025-09-03 09:20:53 - browse：83

The Amgen booth at ESMO in Madrid. Andrew Joseph/STAT

MADRID — A novel type of immunotherapy from Amgen generated strong response rates in patients with advanced small cell lung cancer, results that could lead to the approval of the drug.

The data, reported here Friday at the annual meeting of European Society for Medical Oncology, come from a Phase 2 trial of the drug, called tarlatamab. But they drew greater interest because Amgen has described the study as “potentially registrational,” and the trial results were also published Friday in the New England Journal of Medicine.

“It’s a single arm study, but the results are amazing,” said Silke Gillessen, the scientific chair of ESMO 2023 and an oncologist at the Oncology Institute of Southern Switzerland, noting that advances in small cell lung cancer have been slow to come.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： 5 important ways Henrietta Lacks changed medical science

focus

WSS

‘Oppenheimer’ and the risks of AI in health care

Amylyx ALS drug failure raises questions and concerns

Vertex non

In his State of the Union, Biden takes clear aim at 'Big Pharma'

NIH launches clinical trials and new research office for long Covid

Former medical device CEO who sold dummy, plastic parts convicted of fraud

explore

focus

knowledge

Guidelines to prevent youth baseball injuries need more muscle

Novo Nordisk obesity pill bests Wegovy in early trial

Medicare proposal to cover medical devices draws a mixed reaction

New safety details link Apellis eye drug to rare cases of blindness

Medical records are filled with copy

Change Healthcare payments predicted restored March 15

Hepatitis C has a cure — but many Americans still lack access to it

CDC marks new Covid

Hollywood unions extend contract negotiations for actors

‘Oppenheimer’ and the risks of AI in health care

hotspot

The drug industry has found itself all alone in Washington

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Precocious puberty in girls comes with mental health risks

UnitedHealth quietly bought dozens of outpatient centers

Precocious puberty in girls comes with mental health risks

New safety details link Apellis eye drug to rare cases of blindness

focus

focus

leisure time

explore